Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Schulgit

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Ocular Immunology and Inflammation|April 7, 2026
Risk of Non-Infectious Uveitis Associated with Medications for Substance Use DisordersMatthew J Schulgit, Ashley Hailer, Margaret G Miller, et al.
JAMA Ophthalmology|August 28, 2025
Glucagon-Like Peptide-1 Receptor Agonists and Risk of UveitisNitesh Mohan, Sunil K Srivastava, Matthew J Schulgit, et al.
American Journal of Ophthalmology|January 12, 2026
Exploring the Association Between Autoimmune and Inflammatory Diseases and UveitisNitesh Mohan, Sunil K Srivastava, Matthew J Schulgit, et al.
Retina (Philadelphia, Pa.)|March 12, 2026
Association Between Iris Manipulation during Phacovitrectomy for Retinal Detachment Repair and Proliferative VitreoretinopathySuraj Bala, Nitesh Mohan, Andrea Arline, et al.
American Journal of Ophthalmology|June 23, 2026
Associations Between Routine Vaccinations and the Risk of New-Onset Idiopathic UveitisMatthew J Schulgit, Suraj Bala, Victor Bellanda, et al.
JAMA Ophthalmology|February 5, 2026
Relative Risk of Neovascular Age-Related Macular Degeneration Following Cataract SurgeryVictor Bellanda, Matthew J Schulgit, Gabriel Castilho S Barbosa, et al.
American Journal of Ophthalmology|June 2, 2026
Immune Checkpoint Inhibitor-Associated Uveitis: Insights from Comparative Analyses Across Malignancies and Drug ClassesVictor Bellanda, Matthew J Schulgit, Khaled A Hassan, et al.
Ocular Immunology and Inflammation|January 22, 2026
Impact of Treatment on Inflammatory Choroidal Neovascularization in Patients with SarcoidosisMatthew J Schulgit, Sunil K Srivastava, Gabriel Castilho S Barbosa, et al.
Ophthalmology. Retina|November 20, 2025
Risk Factors and Systemic Outcomes in Patients with Retinal Artery OcclusionAusten N Knapp, Matthew J Schulgit, Sumit Sharma, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 17, 2026
Long-term Outcomes of Faricimab in Previously Treated Neovascular Age-related Macular DegenerationNitesh Mohan, Matthew J Schulgit, Victor Bellanda, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Ocular Immunology and Inflammation|April 7, 2026
Risk of Non-Infectious Uveitis Associated with Medications for Substance Use DisordersMatthew J Schulgit, Ashley Hailer, Margaret G Miller, et al.
JAMA Ophthalmology|August 28, 2025
Glucagon-Like Peptide-1 Receptor Agonists and Risk of UveitisNitesh Mohan, Sunil K Srivastava, Matthew J Schulgit, et al.
American Journal of Ophthalmology|January 12, 2026
Exploring the Association Between Autoimmune and Inflammatory Diseases and UveitisNitesh Mohan, Sunil K Srivastava, Matthew J Schulgit, et al.
Retina (Philadelphia, Pa.)|March 12, 2026
Association Between Iris Manipulation during Phacovitrectomy for Retinal Detachment Repair and Proliferative VitreoretinopathySuraj Bala, Nitesh Mohan, Andrea Arline, et al.
American Journal of Ophthalmology|June 23, 2026
Associations Between Routine Vaccinations and the Risk of New-Onset Idiopathic UveitisMatthew J Schulgit, Suraj Bala, Victor Bellanda, et al.
JAMA Ophthalmology|February 5, 2026
Relative Risk of Neovascular Age-Related Macular Degeneration Following Cataract SurgeryVictor Bellanda, Matthew J Schulgit, Gabriel Castilho S Barbosa, et al.
American Journal of Ophthalmology|June 2, 2026
Immune Checkpoint Inhibitor-Associated Uveitis: Insights from Comparative Analyses Across Malignancies and Drug ClassesVictor Bellanda, Matthew J Schulgit, Khaled A Hassan, et al.
Ocular Immunology and Inflammation|January 22, 2026
Impact of Treatment on Inflammatory Choroidal Neovascularization in Patients with SarcoidosisMatthew J Schulgit, Sunil K Srivastava, Gabriel Castilho S Barbosa, et al.
Ophthalmology. Retina|November 20, 2025
Risk Factors and Systemic Outcomes in Patients with Retinal Artery OcclusionAusten N Knapp, Matthew J Schulgit, Sumit Sharma, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 17, 2026
Long-term Outcomes of Faricimab in Previously Treated Neovascular Age-related Macular DegenerationNitesh Mohan, Matthew J Schulgit, Victor Bellanda, et al.
Pageof 2